These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19084295)

  • 1. Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors.
    Dündar Y; Unlü S; Banoğlu E; Entrena A; Costantino G; Nuñez MT; Labeaga L; Sahin MF; Noyanalpan N
    Eur J Med Chem; 2009 May; 44(5):1830-7. PubMed ID: 19084295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors.
    Eren G; Unlü S; Nuñez MT; Labeaga L; Ledo F; Entrena A; Banoğlu E; Costantino G; Sahin MF
    Bioorg Med Chem; 2010 Sep; 18(17):6367-76. PubMed ID: 20692174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Dec; 13(23):6425-34. PubMed ID: 16099663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Kakhgi S; Hadipoor A; Daraee B; Dadrass OG; Hedayati M
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1336-9. PubMed ID: 18226898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective COX-2 inhibitors. Part 1: synthesis and biological evaluation of phenylazobenzenesulfonamides.
    Tsai WJ; Shiao YJ; Lin SJ; Chiou WF; Lin LC; Yang TH; Teng CM; Wu TS; Yang LM
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4440-3. PubMed ID: 16814546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors.
    Ghodsi R; Zarghi A; Daraei B; Hedayati M
    Bioorg Med Chem; 2010 Feb; 18(3):1029-33. PubMed ID: 20061161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
    El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
    Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.
    Zarghi A; Ghodsi R; Azizi E; Daraie B; Hedayati M; Dadrass OG
    Bioorg Med Chem; 2009 Jul; 17(14):5312-7. PubMed ID: 19560931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors.
    Cheng H; Lundy DeMello KM; Li J; Sakya SM; Ando K; Kawamura K; Kato T; Rafka RJ; Jaynes BH; Ziegler CB; Stevens R; Lund LA; Mann DW; Kilroy C; Haven ML; Nimz EL; Dutra JK; Li C; Minich ML; Kolosko NL; Petras C; Silvia AM; Seibel SB
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2076-80. PubMed ID: 16464588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective COX-2 inhibitors. Part 2: synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides.
    Lin SJ; Tsai WJ; Chiou WF; Yang TH; Yang LM
    Bioorg Med Chem; 2008 Mar; 16(5):2697-706. PubMed ID: 18063374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation, and enzyme docking simulations of 1,5-diarylpyrrole-3-alkoxyethyl ethers as selective cyclooxygenase-2 inhibitors endowed with anti-inflammatory and antinociceptive activity.
    Anzini M; Rovini M; Cappelli A; Vomero S; Manetti F; Botta M; Sautebin L; Rossi A; Pergola C; Ghelardini C; Norcini M; Giordani A; Makovec F; Anzellotti P; Patrignani P; Biava M
    J Med Chem; 2008 Aug; 51(15):4476-81. PubMed ID: 18598017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of 1,3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors.
    Zarghi A; Zebardast T; Hakimion F; Shirazi FH; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Oct; 14(20):7044-50. PubMed ID: 16798002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, syntheses, biological evaluation, and docking studies of 2-substituted 5-methylsulfonyl-1-phenyl-1H-indoles: potent and selective in vitro cyclooxygenase-2 inhibitors.
    Cruz-López O; Díaz-Mochón JJ; Campos JM; Entrena A; Núñez MT; Labeaga L; Orjales A; Gallo MA; Espinosa A
    ChemMedChem; 2007 Jan; 2(1):88-100. PubMed ID: 17131462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of N-acetyl-2-carboxybenzenesulfonamides: a novel class of cyclooxygenase-2 (COX-2) inhibitors.
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2005 Apr; 13(7):2459-68. PubMed ID: 15755648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 2-(4-methylsulfonylphenyl)pyrimidine derivatives as highly potent and specific COX-2 inhibitors.
    Orjales A; Mosquera R; López B; Olivera R; Labeaga L; Núñez MT
    Bioorg Med Chem; 2008 Mar; 16(5):2183-99. PubMed ID: 18158247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and pharmacological evaluation of 4-[2-alkylthio-5(4)-(4-substitutedphenyl)imidazole-4(5)yl]benzenesulfonamides as selective COX-2 inhibitors.
    Salimi M; Ghahremani MH; Naderi N; Amini M; Salimi E; Amanlou M; Abdi K; Salehi R; Shafiee A
    Acta Pharmacol Sin; 2007 Aug; 28(8):1254-60. PubMed ID: 17640491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship of novel, highly potent metharyl and methcycloalkyl cyclooxygenase-2 (COX-2) selective inhibitors.
    Khanapure SP; Garvey DS; Young DV; Ezawa M; Earl RA; Gaston RD; Fang X; Murty M; Martino A; Shumway M; Trocha M; Marek P; Tam SW; Janero DR; Letts LG
    J Med Chem; 2003 Dec; 46(25):5484-504. PubMed ID: 14640557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors.
    Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Ortuso F; Alcaro S; Cirilli R
    Eur J Med Chem; 2010 Dec; 45(12):6135-8. PubMed ID: 20974503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of 3-alkyl-2-aryl-1,3-thiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zebardast T; Zarghi A; Daraie B; Hedayati M; Dadrass OG
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3162-5. PubMed ID: 19447036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethyl-4-oxo-4,5,6,7-tetrahydroindazole-1-acetic acid: a new lead compound with selective COX-2 inhibitory activity.
    Abdel-Rahman HM; Ozadali K
    Arch Pharm (Weinheim); 2012 Nov; 345(11):878-83. PubMed ID: 22907715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.